Development of an inactivated vaccine candidate for SARS-CoV-2

Cited by (1,435)

Items 1,101–1,200 of 1,435

1. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people.
   Claudia Colombo, Laura Garatti, Giulia Ferrante, Francesca Casadei, Claudio Montalto, Gabriele Crimi, Chiara Beatrice Cogliati, Enrico Ammirati, Stefano Savonitto, Nuccia Morici · 2021 · PubMed Central
2. Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
   Teddy Stephen Ehianeta, Said Abdulrahman Salim Mzee, Adebisi Muslimat Kehinde, Oluwayemisi Ehianeta · 2021 · Infectious Microbes & Diseases
3. Dendritic cell-based COVID-19 vaccines: A mini review
   Dewi Pertiwi, Ihsanul Hafiz, Didi Nurhadi Illian · 2021 · Journal of Research in Pharmacy
4. VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION
   Alev BAŞARAN, Barış Çil · 2022 · Journal of Contemporary Medicine
5. Association of severity and mortality of Covid-19 cases among acute kidney injury and sexual dimorphism
   Mukul Kumar Singh, Mayank Jain, Hari Shyam, Dinesh Kumar Sahu, Archana Mishra, Pratap Shankar, Shailendra Kumar, Vishwajeet Singh · 2022 · Molecular Biology Reports
6. Perang Melawan Bahaya Hoaks COVID-19 di Dunia
   Ridwan Balatif · 2021 · JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia
7. Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
   Amir Rezaei, Shahram Nazarian, Hossein Samiei-Abianeh, Emad Kordbacheh, Zahra Alizadeh, Seyed Latif Mousavi Gargari · 2022 · Avicenna Journal of Medical Biotechnology
8. Higher benefit-risk ratio of COVID-19 vaccination in patients with schizophrenia and major depressive disorder versus patients with bipolar disorder when compared to controls.
   Jingjing Zhu, Hongjun Tian, Haibo Wang, Haiping Yu, Chuanxin Liu, Lina Wang, Qianchen Li, Tao Fang, Feng Jia, Yachen Li et al. · 2022 · PubMed
9. How do the severe acute respiratory coronavirus 2 (SARS-CoV-2) and its variants escape the host protective immunity and mediate pathogenesis?
   Rashed Noor · 2022 · Bulletin of the National Research Centre/Bulletin of the National Research Center
10. Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees
    Letícia Carrijo Masson, Carolina do Prado Servian, Vitor Hugo Jardim, Déborah Carolina Carvalho dos Anjos, Miriam Leandro Dorta, João Victor Batalha-Carvalho, Ana Maria Moro, Pedro Roosevelt Torres Romão, Menira Borges Lima Dias Souza, Fabíola Souza Fiaccadori et al. · 2023 · Vaccines
11. One-Step Electrocatalytic Approach Applied to the Synthesis of β-Propiolactones from CO2 and Dienes
    Renate Schwiedernoch, Xiaofeng Niu, Haosheng Shu, Stephan N. Steinmann, Mengjia Wu, Negar Naghavi · 2023 · The Journal of Organic Chemistry
12. Technologies for Making New Vaccines
    Simone Pecetta, Sohail Ahmed, Ronald W. Ellis, Rino Rappuoli · 2023 · Elsevier eBooks
13. Antibody Response to SARS-CoV-2 Vaccination in Heart Failure Patients: Retrospective Single-Center Cohort Study
    Defne Güneş Ergi, Ümit Kahraman, Gözde Akkuş Kayalı, Seyfi Durmaz, Özlem Balcıoğlu, Çağatay Engin, Burcu Yağmur, Sanem Nalbantgil, Candan Çiçek, Mustafa Özbaran et al. · 2023 · Diagnostics
14. Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19
    Kamshat Shorayeva, Наханов Азиз Куралбаевич, Ainur Nurpeisova et al. · 2023 · Vaccines
15. Innovation-driven trend shaping COVID-19 vaccine development in China
    Yuntao Zhang, Yuxiu Zhao, Hongyang Liang, Ying Ming Xu, Chuge Zhou, Yuzhu Yao, Hui Wang, Xiaoming Yang · 2023 · Frontiers of Medicine
16. Evaluation of Immune Response to Mucosal Immunization with an Oral Probiotic-Based Vaccine in Mice: Potential for Prime-Boost Immunization against SARS-CoV-2
    Galina Leontieva, Tatiana V. Gupalova, Yulia A. Desheva, Tatiana A. Kramskaya, Elena Bormotova, I. V. Koroleva, Olga S. Kopteva, Alexander N. Suvorov · 2023 · International Journal of Molecular Sciences
17. Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay
    Armel Landry Batchi-Bouyou, Jean Claude Djontu, Line Lobaloba Ingoba, Jiré Séphora Mougany, Freisnel Hermeland Mouzinga, Jacques Dollon Mbama Ntabi, Franck Yannis Kouikani, Arcel Christ Massamba Ndala, Steve Diafouka-Kietela, Raoul Ampa et al. · 2024 · BMC Immunology
18. Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS‐CoV‐2 neutralization
    Veronica Aparecida de Lima, João Paulo Silva Nunes, Daniela Santoro Rosa, Rodrigo da Silva Ferreira, Maria Luiza Vilela Oliva, Robert Andreata‐Santos, Márcia Duarte-Barbosa, Luiz Mário Janini, Juliana Terzi Maricato, Milena Apetito Akamatsu et al. · 2024 · Immunity Inflammation and Disease
19. Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
    Diego A. Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A. Muena, Pablo Díaz, Gisselle N. Barra, Rodrigo Puentes, Daniel F. Escobar, Michal Díaz-Samirin, Natalia T. Santis-Alay, Cecilia Canales et al. · 2024 · Vaccines
20. A Universidade do Minho em tempos de pandemia: Tomo II: Re(Ações)
    Manuela Martins, Elóy Rodrigues · 2020 · UMinho Editora eBooks
21. Spatiotemporal Differences of COVID-19 Infection Among Healthcare Workers and Patients in China From January to March 2020
    Peixiao Wang, Xinyan Zhu, Wei Jie Guo, Hui Ren, Tao Hu · 2021 · IEEE Access
22. A Comprehensive Review of Possible Immune Responses against Novel SARS-CoV-2 Coronavirus: Vaccines Strategies and Challenges
    Shahriar A, Mahmud AR, Hanem M. Ahmed, Nabidur Rahman, Khatun MC · 2021 · Austin Journal of Microbiology
23. Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology
    А. А. Чепурнов, E. I. Kazachinskaya, E. A. Kazachkova · 2021 · Bulletin of Experimental Biology and Medicine
24. SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
    Rahnuma Ahmad · 2021 · Bangladesh Journal of Medical Science
25. Is it time to start COVID-19 vaccination in pregnant women?
    Muhammad Ilham Aldika Akbar · 2021 · Majalah Obstetri & Ginekologi
26. Recent Update of COVID-19 Vaccines
    Sameer A. Jadaan, Abdul Waheed Khan · 2021 · Advanced Pharmaceutical Bulletin
27. Efektivitas Vaksin Covid-19 dalam Kinerjanya untuk Memodulasi Imunitas Tubuh Melawan Infeksi SARS-COV-2
    Andika Ridwan Nugraha Harahap · 2022 · Indonesian Journal of Nursing and Health Sciences
28. TMPRSS2 Protease Inhibitors May Prolong But Heparins Accelerate SARS-CoV-2 Clearance
    Shu Yuan, Sicong Jiang, Zhongwei Zhang, Zi-Lin Li, Changquan Wang, Ming Zhe Yuan, Yang‐Er Chen, Qi Tao, Ting Lan, Xiaoyan Tang et al. · 2020 · Preprints.org
29. A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection
    Andreas Herrmann, Junki Maruyama, Chanyu Yue et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
30. Early immune response in mice immunized with a semi-split inactivated vaccine against SARS-CoV-2 containing S protein-free particles and subunit S protein
    Marek Petráš, Petr Lesný, Jan Musil, R Limberková, Alžběta Pátíková, Milan Jirsa, Daniel Krsek, P Brezovský, Abhishek Koladiya, Šárka Vaníková et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
31. Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate
    Yinfeng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiangping Li, Pingping Zhou, Xinchun Chen, Xiao Zhang, Xiaohui Yu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
32. Intranasal Administration of ACIS KEPTIDE™ Prevents SARS-CoV2-Induced Acute Toxicity in K18-hACE2 Humanized Mouse Model of COVID-19: A Mechanistic Insight for the Prophylactic Role of KEPTIDE™ in COVID-19
    Gunnar Gottschalk, James F Keating, Kris Kesler · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
33. The architecture of the SARS-CoV-2 RNA genome
    Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Yu Rao, Naijing Hu, Minnan Yang, Xiaorui Xing, Bing Zhou, Xiangxi Wang, Jianwei Wang et al. · 2020 · Research Square
34. The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infection
    Zezhong Liu, Wei Xu, Shuai Xia, Chenjian Gu, Xinling Wang, Qian Wang, Jie Zhou, Yan‐Ling Wu, Xia Cai, Di Qu et al. · 2020 · Research Square
35. A single dose of an adenovirus-vectored vaccine provides complete protection of the upper and lower respiratory tracts against SARS-CoV-2 challenge
    Shipo Wu, Gongxun Zhong, Jun Zhang et al. · 2020
36. Impact of Prior Infection on Protection and Transmission of SARS-CoV-2 in Golden Hamsters
    Cheng Zhang, Zhendong Guo, Nan Li, Huan Yong Cui, Keyin Meng, Lina Liu, Li Zhao, Shanshan Zhang, Cheng‐Feng Qin, Juxiang Liu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
37. Combinatorial mRNA vaccination enhances protection against SARS-CoV-2 delta variant
    Renee L. Hajnik, Jessica A. Plante, Yuejin Liang, Mohamad‐Gabriel Alameh, Jinyi Tang, Chaojie Zhong, Awadalkareem Adam, Dionna Scharton, Grace H. Rafael, Yang Liu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
38. A Translatable Subunit Nanovaccine for COVID-19
    Lixin Liu, Zhijia Liu, Haolin Chen, Hong Liu, Qiang Gao, Feng Cong, Guangxia Gao, Yongming Chen · 2020 · ChemRxiv
39. Replication‐Competent Viral Vectors for Vaccine Delivery
    Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, Divya Teli, Amit Z. Chaudhari, Shahnaz Alom · 2025
40. Human Challenge Studies with Coronaviruses Old and New
    Richard McKendry, Nana‐Marie Lemm, Loukas Papargyris, Christopher Chiu · 2021 · Current topics in microbiology and immunology
41. Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs Against COVID-19
    Amy V. Paschall, Fikri Y. Avci · 2022 · Royal Society of Chemistry eBooks
42. The Concept of Compensation for Land Rights in Land Procurement for Public Interests
    Rizky Ramadhan, Sri Winarsi · 2023 · El-Hekam
43. Frequency And Factors Associated With Adverse Reactions After Administration of Inactivated COVID-19 Vaccine Among Health Workers
    Beray Gelmez Taş, İlknur Demir, Muhammed Basanmay · 2023 · Revista da Sociedade Brasileira de Medicina Tropical
44. Bioreactor design for vaccine production
    Meheria Hazari, Tarumoy Das, Surabhi Chaudhuri · 2024 · Elsevier eBooks
45. Relative effectiveness of COVID-19 vaccine booster doses in people aged 65 and older—a retrospective cohort study in Türkiye
    Mehmet Akif Sezerol, Alican Sarısaltık · 2024 · Therapeutic Advances in Vaccines and Immunotherapy
46. Re-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines
    Weiyu Jiang, Jianbo Wu, Jiaying He, Anqi Xia, Wei Wu, Yidan Gao, Qianqian Zhang, Xiaofang Peng, Qiaochu Jiang, Song Xue et al. · 2024 · Vaccines
47. Immunological considerations for COVID-19: Vaccines and other protective strategies
    Dragan Primorac, Kristijan Vrdoljak, Tomabu Adjobimey, Marijo Parčina · 2025 · Elsevier eBooks
48. A Poly-Lysine-Based RBD Mucosal Vaccine Induces Potent Antibody Responses in Mice
    Huifang Xu, Han Wang, Peng Sun, Tiantian Wang, Bin Zhang, Xuchen Hou, Jun Wu, Bo Liu · 2025 · Vaccines
49. Sneddon-Wilkinson Disease Induced by COVID-19 Vaccine: An Unusual Presentation
    Riqu Cao, Tianhong Xu · 2025 · Clinical Cosmetic and Investigational Dermatology
50. Modeling Virus-Associated Central Nervous System Disease in Non-Human Primates
    Krystal J. Vail, Brittany N. Macha, Linh Hellmers, Tracy Fischer · 2025 · International Journal of Molecular Sciences
51. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trial
    José Moreira, Elizabeth González Patiño, Patricia Emília Braga et al. · 2025 · Vaccine
52. Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses
    Beatriz L. L. Caetano, Paolla Beatriz Almeida Pinto, Agatha R. Pacheco, Agnes R. Lage, Aline Pereira, Amanda V. P. Nascimento, Thiago R. Machado, Anderson Paulino, Thiago L. Medeiros, Lorena O. Fernandes-Siqueira et al. · 2025 · Frontiers in Immunology
53. Patterns of restricted TCR usage following SARS-CoV-2 vaccination and severe disease
    Emily L. Parsons, Zhongyan Lu, Stephanie A Richard, Amanda E Zelkoski, Janifer Le, Naraen Palanikumar, Phuong Nguyen, Camille Alba, Gauthaman Sukumar, John G. Rosenberger et al. · 2025 · Frontiers in Immunology
54. Kinetics of IgA Subtypes and Cytokines in Respiratory Secretions Following Immunization With COVID‐19 Mucosal Vaccine
    Weixin Chen, Juan Li, Shuang Bai, Ao Zhang, Qun Zheng, Junnan Zhang, Wenwen Lan, Yihan Zhang, Wei Yao, Wei Zhao et al. · 2025 · Journal of Medical Virology
55. Um ano com a pandemia da COVID-19: reflexões e aprendizados nas instituições de longa permanência
    Guilherme Rossini, Maria Auxiliadora Craice De Benedetto, Graziela Moreto · 2021 · Acta Fisiátrica
56. Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19)
    Rajendra Awasthi, Anurag Kumar Singh, Anand Maurya · 2021 · Recent Patents on Nanotechnology
57. Radiotherapy in Cancer Treatment During The Covid-19 Pandemic: One Year Results From Northeast Turkey
    Özlem Aynaci · 2022 · Turkish Journal of Oncology
58. Dynamics of specific antibodies in COVID-19 patients after recovery
    Zhi-Bo Deng, Feng Cheng, Yong Zhang · 2022 · Epidemiology and Infection
59. Investigation of highly cited publications related to vaccines against COVID-19: current state and future predictions
    Ali Kemal Erenler, Mehmet Oguzhan AY, Özlem Oymak Ay · 2022 · Bratislavské lekárske listy/Bratislava medical journal
60. Antibody response to SARS-CoV-2 vaccines among hospitalized patients in China: a case-control study
    Feiping Li, Guifeng Shi, Zhenzhen Lin, Xiaoliang Zhu, Li-Jun Wang, Tao‐Hsin Tung, Meixian Zhang · 2022 · Human Vaccines & Immunotherapeutics
61. Experimental Models of SARS-COV-2 Infection in the Central Nervous System
    Anna Maria Paoletti, Maria Grazia Melilli, Immacolata Vecchio · 2022 · Journal of Central Nervous System Disease
62. Vaccine History: From Smallpox to Covid-19
    Camila Puton, Fernanda Gabriel Aires Saad, Ricelly Pires Vieira, Eduarda de Soares Libânio, Vinícius Barreto da Silva, Wilson de Melo Cruvinel, Leonardo Luíz Borges, Carlton Anthony Taft, Clayson Moura Gomes · 2022 · Engineering materials
63. Integrated Multi-Omic Characterization of the Detachment Process of Adherent Vero Cells with Animal-Based and Animal-Origin-Free Enzymes
    Shouzhi Yu, Yunchao Huang, Chongyang Wu, Weibin Fu, Hongyang Liang, Chen Chen, Yue Cheng, Yancen Guo, Ying Zhang, Hui Wang et al. · 2022 · Cells
64. An Automated Strategy to Handle Antigenic Variability in Immunisation Protocols, Part II: In Vitro Transcribed mRNA Vector Design for Inoculation Against Infectious Agent Variants
    Glaucia C. Pereira · 2022 · Methods in molecular biology
65. STATUS OF COVID-19 IN THE WORST AFFECTED TWENTY COUNTRIES AND THE WORLD AT THE END OF 2020
    Rushikesh G. Joshi, Kiransinh Narendrasinh Rajput, Vikram H. Raval, Prashant Arya, Rinkal B. Gohil, Aanal N. Patani, Kalpesh L. Mahla, Jaimin B. Pandya, Rakeshkumar Ramanlal Panchal · 2021 · Towards Excellence
66. Evaluation of SARS-CoV-2 Antibody Levels in Pharmacists and Pharmacy Staff Following CoronaVac Vaccination
    Güneş Ünal, Simla Dilara SEZGİN, Mesut Sancar · 2023 · Turkish Journal of Pharmaceutical Sciences
67. An integrative literature review on the SARS-CoV-2 virus from 2015 to 2022
    Cristian dos Santos Pereira, Joelson Rodrigues Farias, Maria Cláudia Pinheiro Corôa · 2023 · Brazilian Journal of Health Review
68. Deep learning for Twitter sentiment analysis about the pros and cons of Covid-19 vaccines in Indonesia
    Dinar Ajeng Kristiyanti, Ahmad Al Kaafi, Esty Purwaningsih · 2023 · AIP conference proceedings
69. Comprehensive Review of the Initial 11 WHO Emergency Use Listed COVID-19 Vaccine Candidates: Mechanisms, Efficacy, and Comparative Attributes for Safety and Well-Being
    Kumari Aditi, Nikki Kumari, Poonam Singh, Abha Kumari, SNP Yadav Deen, Roshan Kumar · 2023 · Microsphere
70. Previous and potential mutations of Sars-cov-2 receptors and their interaction with known inhibitors
    Emmanuel Chuks Oranu, Adanna Ijeawele, Roselyn Nneka Egbuna, Ebere Ifejirika Ezeonyi, Chukwubuikem Chinaeze Okolo, Ikemefuna Chijioke Uzochukwu · 2023 · GSC Biological and Pharmaceutical Sciences
71. Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile
    Nicole Le Corre, Katia Abarca V, Patricio Astudillo P., Marcela Potı́n, Sofía López, Macarena Goldsack, Vania Valenzuela, Andrea Schilling R, Victoria Gaete, Lilian Rubio et al. · 2023 · Vaccines
72. The Long-Term Serological Profile of CoronaVac Vaccine Based on Comorbidities and History of SARS-CoV-2 Infection in Indonesia
    Syahrul Chilmi, Tanti Adelia Kesuma, Purwa Adrianta Wibawa, Hani Susianti, Agustin Iskandar, Indah Adhita Wulanda, Cesarius Singgih Wahono, Kusworini Handono · 2023 · Japanese Journal of Infectious Diseases
73. Efficacy of SARS-CoV-2 detection from used surgical masks compared with standard detection method
    Uraporn Phumisantiphong, Anan Manomaipiboon, Yuttana Apichatbutr, Kittisak Pholtawornkulchai, Chunlanee Sangketchon, Busaba Supawattanabodee, Thananda Trakarnvanich · 2023 · Biosafety and Health
74. Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus
    A. S. Ivanovsky, I. A. Kolesnikov, Yu. V. Kordonskaya · 2023 · Crystallography Reports
75. Immunological Interventions for the Management of Coronavirus Disease 2019 (COVID-19)
    Ramswaroop Singh Chauhan, Yashpal Singh Malik, M. Saminathan, Bhupendra Nath Tripathi · 2024 · Springer eBooks
76. Attitudes of health care workers toward COVID-19 vaccination: A literature review
    Daria Łaskawiec-Żuławińska, Marika Wlazło, Mateusz Krystian Grajek, Ilona Korzonek-Szlacheta · 2023 · Applied Psychology Research
77. Uveitis following COVID-19 vaccination in the pediatric population: Experience at a tertiary referral hospital
    Budoor Alsalman, Abdulrahman F. AlBloushi, Asma Alzuabi · 2024 · Journal Français d Ophtalmologie
78. Label-Free Quantitative Proteomics Analysis of COVID-19 Vaccines by Nano LC-HRMS
    Hengzhi Zhao, Wendong Li, Jingjing Liu · 2024 · Vaccines
79. CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters
    Jyotsna Dandotiya, Neeta Adhikari, Manas Ranjan Tripathy, Kamini Jakhar, Sudipta Sonar, Dibya Ranjan Pati, Vibhu Kanchan, Varsha S. Prasad, Jitendra Kumar, Nitesh K. Senapati et al. · 2025 · Frontiers in Immunology
80. Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve
    Enes Karaman, Adem Yavuz, Erol Karakaş, Esra Balcıoğlu, Busra Karaca, Hande Nur Doganay, Koray Görkem Saçıntı, Orhan Yıldız · 2025 · Vaccines
81. Dynamic Changes in Antibodies and Proteome in Breast Milk of Mothers Infected with Wild-Type SARS-CoV-2 and Omicron: A Longitudinal Study
    Yaqiong Guo, Cheng Li, Minjie Tan, Yuexiao Chen, Shuai Zhu, Cheng Zhi, Jing Zhu · 2025 · Nutrients
82. Contribution of antibody-dependent enhancement to the pathogenesis of coronavirus infections
    Yulia A. Desheva, A. S. Mamontov, Peter G. Nazarov · 2020 · AIMS Allergy and Immunology
83. Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome- Corona Virus 2 (SARS-COV-2)
    Jaison Jeevanandam, Subhamoy Banerjee, Rajkumar Paul · 2020
84. Biological features of SARS-CoV-2 and current approaches to antiviral therapy and vaccination
    Snježana Židovec Lepej, Petra Korać, Dijana Škorić, Margarita Batović, Paula Gršković, Valerija Begić, Suzana Harabajsa, Leona Radmanić, Petra Šimičić · 2020 · Molecular and experimental biology in medicine
85. COVID-19 vaccines: Where do we stand?
    Pınar Tulay, Mahmut Çerkez Ergören, Munis Dündar · 2021 · The EuroBiotech Journal
86. Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting
    Jun Huang, Lu Zhang, Shengjun Wu et al. · 2021 · Annals of Translational Medicine
87. SARS-CoV-2 vaccines: A brief review
    Brandon Chatani, DanielK Ng · 2020 · Pediatric Respirology and Critical Care Medicine
88. Introduction to COVID-19
    Naheed Bano, Fatima Batool, May Nasser Bin-Jumah · 2021 · Springer eBooks
89. Therapy of COVID-19: vaccines and drugs
    Jolanta Barbara Zawilska, Katarzyna Kuczyńska, Magdalena Gawior, Martyna Kosiorek, Katarzyna Dąbrowska, Zuzanna Dominiak, Amelia Baranowska, Gabriela Skorupska, Agnieszka Sujecka, Klaudia Michalak et al. · 2021 · Farmacja Polska
90. Lethal Human Coronavirus Infections and the Role of Vaccines in Their Prevention
    Jeremy Baldwin, Nikolai Petrovsky · 2021 · Springer eBooks
91. COVID-19 vaccine: Potential candidates, achievements, and challenges
    Muhammad Shoaib, Ahmad Waheed, Muhammad Wajid, Hafiza Urwa, Tehmina Saleem Khan, Muhammad Saleem Khan, Muhammad Waseem Aslam, Shabbir Ahmad, Kamran Jafar, Hasnain Akmal et al. · 2021 · GSC Biological and Pharmaceutical Sciences
92. CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSIAN TRANSLATION)
    Y.-D. Li, Wei-Yu Chi, Jun-Han Su, Louise Ferrall, Chien‐Fu Hung, T.‐C. Wu · 2020 · Juvenis scientia
93. SARS-CoV-2 Infection and Antibody-Dependent Enhancement
    Aliye Baştuğ, Hürrem Bodur · 2021 · Studies in computational intelligence
94. Therapeutic Strategies for Treatment of COVID-19
    Lahcen Tamegart, Mjid Oukhrib, Hafida El Ghachi · 2021 · Advances in human services and public health (AHSPH) book series
95. Vaccine Development and Immune Responses in COVID-19: Lessons from the Past
    Fataneh Fatemi, Zahra Hassani Nejad, Seyed Ehsan Ranaei Siadat · 2021 · Springer eBooks
96. Study protocol for a randomized, open-label, non-controlled Phase I/II Study to assess safety and immunogenicity of twice or three times dosing of intramuscular COVID-19 DNA vaccine in healthy adults
    Hironori Nakagami A, Hiroki Hayashi, Tetsuya Ishihama et al. · 2021 · Translational and Regulatory Sciences
97. SARS-COV-2 vaccine: First-month results of a six-month follow-up study
    Burak Mete, Ferdi Tanır, Hakan Demırhındı · 2021 · TURKISH JOURNAL OF MEDICAL SCIENCES
98. Investigation of the Cognitive Attitudes and Behaviors of Medical Post-graduates in Clinical Practice During the COVID-19 Pandemic in China
    Lei Feng, Zefeng Xie, Junhui Shen · 2021 · Frontiers in Public Health
99. The impact and effectiveness of new coronavirus vaccine on disease outcome worldwide
    Tasneem A. Alkout, Abdulhamid M. Alkout · 2021 · Iberoamerican Journal of Medicine
100. COVID-19 Vaccination to realize Green Zones in Bali
     Ida Ayu Agung Adnyawati · 2021 · Bali Tourism Journal